Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2017 (2017), Article ID 3132729, 7 pages
https://doi.org/10.1155/2017/3132729
Research Article

Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors

Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence should be addressed to Mohsen Janghorbani

Received 11 July 2017; Revised 18 October 2017; Accepted 23 November 2017; Published 20 December 2017

Academic Editor: Tomohiro Katsuya

Copyright © 2017 Mohsen Janghorbani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Christlieb, J. H. Warram, A. S. Królewski et al., “Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics.,” Diabetes, vol. 30, no. 2, pp. 90–96, 1981. View at Publisher · View at Google Scholar · View at Scopus
  2. H.-H. Parving, A. Andersen, U. Smidt, and P. Svendsen, “Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy,” The Lancet, vol. 1, no. 8335, pp. 1175–1179, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. C. E. Mogensen, “Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy,” BMJ, vol. 285, no. 6343, pp. 685–688, 1982. View at Publisher · View at Google Scholar
  4. A. Teuscher, H. Schnell, and P. W. F. Wilson, “Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure,” Diabetes Care, vol. 11, no. 3, pp. 246–251, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Klein, B. E. K. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?” JAMA Internal Medicine, vol. 149, no. 11, pp. 2427–2432, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Arauz-Pacheco, M. A. Parrott, and P. Raskin, “The treatment of hypertension in adult patients with diabetes.,” Diabetes Care, vol. 25, no. 1, pp. 134–147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Rossing, P. Hougaard, K. Borch-Johnsen, and H.-H. Parving, “Predictors of mortality in insulin dependent diabetes; 10 year observational follow up study,” British Medical Journal, vol. 313, no. 7060, pp. 779–784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Y.-Z. Forrest, D. J. Becker, L. H. Kuller, S. K. Wolfson, and T. J. Orchard, “Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same?: A prospective study,” Atherosclerosis, vol. 148, no. 1, pp. 159–169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Maahs, G. L. Kinney, P. Wadwa et al., “Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population,” Diabetes Care, vol. 28, no. 2, pp. 301–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Collado-Mesa, H. M. Colhoun, L. K. Stevens et al., “Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM complications study,” Diabetic Medicine, vol. 16, no. 1, pp. 41–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. B. Gomes, L. R. M. Tannus, A. S. D. M. Matheus et al., “Prevalence, awareness, and treatment of hypertension in patients with type 1 diabetes: a nationwide multicenter study in Brazil,” International Journal of Hypertension, vol. 2013, Article ID 565263, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Roy, M. N. Janal, and A. Roy, “Medical and psychological risk factors for incident hypertension in type 1 diabetic African-Americans,” International Journal of Hypertension, vol. 2011, Article ID 856067, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Dahl-Jørgensen, J. R. Larsen, and K. F. Hanssen, “Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?” Diabetologia, vol. 48, no. 8, pp. 1445–1453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. L. Rodriguez, D. Dabelea, A. D. Liese et al., “Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: The search for diabetes in youth study,” Journal of Pediatrics, vol. 157, no. 2, pp. 245.e1–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. O. Schwab, J. Doerfer, W. Marg, E. Schober, and R. W. Holl, “Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors,” Pediatric Diabetes, vol. 11, no. 5, pp. 357–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. van Vliet, J. C. Van der Heyden, M. Diamant et al., “Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk,” Journal of Pediatrics, vol. 156, no. 6, pp. 923–929, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. D. Margeirsdottir, J. R. Larsen, C. Brunborg, N. C. Øverby, and K. Dahl-Jørgensen, “High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: A population-based study,” Diabetologia, vol. 51, no. 4, pp. 554–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Klein, B. E. K. Klein, K. E. Lee, K. J. Cruickshanks, and S. E. Moss, “The incidence of hypertension in insulin-dependent diabetes,” JAMA Internal Medicine, vol. 156, no. 6, pp. 622–627, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Hajjar and T. A. Kotchen, “Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000,” Journal of the American Medical Association, vol. 290, no. 2, pp. 199–206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Wolf-Maier, R. S. Cooper, H. Kramer et al., “Hypertension treatment and control in five european countries, Canada, and the United States,” Hypertension, vol. 43, no. 1, pp. 10–17, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. S. Geiss, D. B. Rolka, and M. M. Engelgau, “Elevated blood pressure among U.S. adults with diabetes, 1988-1994,” American Journal of Preventive Medicine, vol. 22, no. 1, pp. 42–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. J. I. Barzilay, C. L. Jones, B. R. Davis et al., “Baseline characteristics of the diabetic participants in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT),” Diabetes Care, vol. 24, no. 4, pp. 654–658, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Gnasso, M. C. Calindro, C. Carallo et al., “Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy,” European Journal of Epidemiology, vol. 13, no. 4, pp. 421–428, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Donnelly, L. Molyneaux, M. McGill, and D. K. Yue, “Detection and treatment of hypertension in patients with non-insulin-dependent diabetes mellitus: does the ‘rule of halves’ apply to a diabetic population?” Diabetes Research and Clinical Practice, vol. 37, no. 1, pp. 35–40, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Berlowitz, A. S. Ash, E. C. Hickey, M. Glickman, R. Friedman, and B. Kader, “Hypertension management in patients with diabetes: The need for more aggressive therapy,” Diabetes Care, vol. 26, no. 2, pp. 355–359, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Janghorbani, M. Amini, H. Ghanbari, and H. Safaiee, “Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran,” Ophthalmic Epidemiology, vol. 10, no. 2, pp. 81–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. Levey, J. Coresh, T. Greene et al., “Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate,” Annals of Internal Medicine, vol. 145, pp. 247–254, 2006. View at Google Scholar · View at Scopus
  29. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  30. P. A. James, S. Oparil, B. L. Carter et al., “2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8),” Journal of the American Medical Association, vol. 311, no. 5, pp. 507–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Zgibor, R. R. Wilson, and T. J. Orchard, “Has control of hypercholesterolemia and hypertension in type 1 diabetes improved over time?” Diabetes Care, vol. 28, no. 3, pp. 521–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. I. H. De Boer, B. Kestenbaum, T. C. Rue et al., “Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus,” JAMA Internal Medicine, vol. 168, no. 17, pp. 1867–1873, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. J. Schultz, H. A. Neil, R. N. Dalton, T. Konopelska Bahu, and D. B. Dunger, “Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group,” Diabetes Care, vol. 24, pp. 555–560, 2001. View at Google Scholar